Ausgabe 8/2014
Special Issue: The fascinating and opposing faces of glutamate in health and disease; A Special Issue on Glutamate in Memory of Prof. Vivian Teichberg
Inhalt (21 Artikel)
Glutamate and Vivian Teichberg: a story about science, medicine, memory and love
Mia Levite Teichberg, Peter Riederer
Glutamate in the healthy brain: receptors, effects and mechanisms of action
Glutamate as a neurotransmitter in the healthy brain
Y. Zhou, N. C. Danbolt
The role of glutamate and its receptors in the proliferation, migration, differentiation and survival of neural progenitor cells
Linda C. Jansson, Karl E. Åkerman
Neuronal gap junction coupling as the primary determinant of the extent of glutamate-mediated excitotoxicity
Andrei B. Belousov, Joseph D. Fontes
Part 2:
A further update on the role of excitotoxicity in the pathogenesis of Parkinson’s disease
Giulia Ambrosi, Silvia Cerri, Fabio Blandini
Therapeutic potential of targeting glutamate receptors in Parkinson’s disease
Clare Finlay, Susan Duty
The potential role of kynurenines in Alzheimer’s disease: pathomechanism and therapeutic possibilities by influencing the glutamate receptors
Zsófia Majláth, József Toldi, László Vécsei
The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment
Donald C. Rojas
Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder
Mark J. Niciu, Dawn F. Ionescu, Erica M. Richards, Carlos A. Zarate Jr.
Is there a role for glutamate-mediated excitotoxicity in inflammation-induced depression?
Robert Dantzer, Adam K. Walker
Glutamate and its receptors in cancer
Andrzej Stepulak, Radoslaw Rola, Krzysztof Polberg, Chrysanthy Ikonomidou
The role of glutamate and its receptors in multiple sclerosis
Ivana R. Stojanovic, Milos Kostic, Srdjan Ljubisavljevic
Glutamatergic autoencephalitides: an emerging field
Jessica A. Panzer, Amy J. Gleichman, David R. Lynch
BRAIN TO BLOOD GLUTAMATE SCAVENGING
Brain to blood glutamate scavenging as a novel therapeutic modality: a review
Matthew Boyko, Shaun E. Gruenbaum, Benjamin F. Gruenbaum, Yoram Shapira, Alexander Zlotnik
GLUTAMATE AND ITS RECEPTORS IN THE IMMUNE SYSTEM:
The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells
Yonatan Ganor, Mia Levite
Towards Neuroimmunotherapy for Cancer: the Neurotransmitters Glutamate, Dopamine and GnRH-II augment substantially the ability of T cells of few Head and Neck cancer patients to perform spontaneous migration, chemotactic migration and migration towards the autologous tumor, and also elevate markedly the expression of CD3zeta and CD3epsilon TCR-associated chains
Sven Saussez, Barbara Laumbacher, Gilbert Chantrain, Alexandra Rodriguez, Songhai Gu, Rudolf Wank, Mia Levite
GLUTAMATE RECEPTOR ANTIBODIES IN NEUROLOGICAL DISEASES: Anti-AMPA-GluR3 antibodies, Anti-NMDA-NR1 antibodies, Anti-NMDA-NR2A/B antibodies, Anti-mGluR1 antibodies or Anti-mGluR5 antibodies are present in subpopulations of patients with either: Epilepsy, Encephalitis, Cerebellar Ataxia, Systemic Lupus Erythematosus (SLE) and Neuropsychiatric SLE, Sjogren’s syndrome, Schizophrenia, Mania or Stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate
Mia Levite